Abstract
Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Keywords: apoptosis, baculovirus, caspases, caspase independent
Current Genomics
Title: The p35 Family of Apoptosis Inhibitors
Volume: 5 Issue: 3
Author(s): A. M. Jabbour and C. J. Hawkins
Affiliation:
Keywords: apoptosis, baculovirus, caspases, caspase independent
Abstract: Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Export Options
About this article
Cite this article as:
Jabbour M. A. and Hawkins J. C., The p35 Family of Apoptosis Inhibitors, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349417
DOI https://dx.doi.org/10.2174/1389202043349417 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Haploinsufficiency of DNA Damage Response Genes and their Potential Influence in Human Genomic Disorders
Current Genomics Sulfonated Carbon/Silica Composites: Highly Efficient Heterogeneous Catalysts for the One-Pot Synthesis of Hantzsch 1,4-dihydropyridines, 2,4,5-trisubstituted Imidazoles and 2-arylbenzimidazoles
Current Catalysis Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?
Current Pharmaceutical Design Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Cardiovascular & Hematological Agents in Medicinal Chemistry TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
Current Cardiology Reviews Current Understanding of the Mechanism and Role of ROS in Angiotensin II Signal Transduction
Current Pharmaceutical Biotechnology Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews Theoretical Possibilities for the Development of Novel Antiarrhythmic Drugs
Current Medicinal Chemistry Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Proteomics and Cardiovascular Disease: An Update
Current Medicinal Chemistry Serpinins: Role in Granule Biogenesis, Inhibition of Cell Death and Cardiac Function
Current Medicinal Chemistry Variability in Individual Responsiveness to Aspirin: Clinical Implications and Treatment
Cardiovascular & Hematological Disorders-Drug Targets The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
Current Pharmaceutical Design Central Blood Pressure and End-organ Damage
Current Hypertension Reviews Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Evaluation of Gene and Cell-Based Therapies for Cardiac Regeneration
Current Stem Cell Research & Therapy